Millions Logo
home>us stocks>Alamar Biosciences - Class A
ALMR
Alamar Biosciences - Class AHealthcare
$29.39+$7.39 (+33.61%)in 1 year
as on 30 Oct 2026 at 22:36NASDAQ

Alamar Biosciences - Class A Share Price Today

Alamar Biosciences - Class A opened lower at $33.35, compared with its previous close of $34.04. In the last trading session, the stock traded between $29.36 and $33.85. It showed a downward intraday trend.

return calculator

Time Period

An investment of $100 made 1 year ago in Alamar Biosciences - Class A is now worth

$ 133.61

giving a profit of

$ 33.61 (33.61%)

invest with $1

Note: Past profits do not guarantee future returns.

Analyst Overview

Buy

Rating from 3 Analysts

Buy
66.67%
Hold
33.33%
Sell
0%

Markets Today

Today's Change

$-4.65 (-13.65%)

Day High

$33.85

Day Low

$29.36

Day Open

$33.35

Prev Close

$34.04

Volume

2,77,896

1W Return

-0.89%

1M Return

-9.89%

3M Return

20.58%

6M Return

20.07%

1Y Return

33.61%

Fundamentals

Market Cap ($ Mn)

2,040

PE Ratio

-

PB Ratio

6.82

PEG Ratio

-

ROE

-

ROCE

-24.81%

EPS (TTM)

$-0.19

Investment Returns

1 Week

-0.89%

1 Month

-9.89%

3 Months

20.58%

6 Months

20.07%

9 Months

33.61%

Financials

Quarterly
All values in $ Mn
16.2

Jun 25
29.4

Jun 26

Updates

6Oct

Alamar Biosciences appoints ex-GRAIL CEO Bob Ragusa to board

Bob Ragusa, former GRAIL CEO, joins Alamar Biosciences board. John Brottem appointed as general counsel with MedTech background. Amelia Merrill named Chief People Officer from Guardant Health. Leadership expansion supports scaling of NULISA proteomics platform.

24 days ago

Similar Stocks

StockLTPChange %Market CapPE
$104.57+1.88%$1,80,946.15M36.28
$448.76+1.03%$1,55,559.96M42.73
$97.11+2.46%$1,24,220.20M24.46
$311.75+2.55%$1,19,578.88M34.27
$42.69+0.61%$61,867.63M18.96
$94.44+2.90%$54,435.22M53.70
$198.34+1.63%$54,025.24M44.07
$252.83+1.06%$35,557.76M23.04
$76.42+0.79%$34,552.39M16.49
$71.13+1.86%$34,384.24M54.55
$79.93+1.67%$30,162.46M36.04
$416.67+3.23%$29,323.57M43.21